Is there any evidence to suggest ixekizumab is more effective in certain psoriasis phenotypes or patient subgroups?

Featuring Tina Bhutani, MD, MAS | CEO, Synergy Dermatology Associate Clinical Professor of Dermatology University of California, SF San Francisco, CA | Published October 18, 2024